Search Results 81-90 of 15281 for CLL
-
A Study Of APG-2575 Alone Or In Combination With Other Therapeutic Agents To Treat Relapsed And/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
Mayo Clinic doctors and scientists are actively studying new ways of treating chronic lymphocytic leukemia. Blood cell and bone marrow cancer research is ...
-
AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...
-
Venetoclax is used alone or together with other medicines (eg, acalabrutinib, obinutuzumab, rituximab) to treat chronic lymphocytic leukemia (CLL) or small ...
-
This medicine is also used in combination with other medicines (eg, obinutuzumab, venetoclax) to treat chronic lymphocytic leukemia (CLL) or small lymphocytic ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy ... Venetoclax is FDA approved for the treatment of CLL and SLL. The drug ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...